Nutritional Considerations in Patients with Hepatic Failure

  • A. Sastre Gallego
  • E. Morejón Bootello
  • P. Carda Abella
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 341)

Abstract

The evolution of the patients affected by chronic hepatopathy is a problem which results in a high percentage of surgical interventions. Portal hypertension leads to one of the most serious dangers for the lives of these patients: upper digestive hemorrhage with its hemodynamic and metabolic sequels. The situation is dramatized by an ever — increasing circumstance: the ethylic origen of the hepatic lesion strikes in increasingly younger ages, or in the best of cases, in the middle stages of life. It must be pointed out that the consumption of pure ethanol “per capita” annually in Spain is 13 liters. The consumption of beer has risen to 50 liters; wine consumption remains at 60 liters and spirits of 40° at 7.5 liters per capita and year [1].

Keywords

Osteoporosis Serotonin Pyruvate Folate Tryptophan 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Caballeria, J. and Pares, A., Alcohol e hígado en enfermedades digestivas. Ediciones CEA, Madrid, 1990, pp. 2103–2117.Google Scholar
  2. 2.
    Pomar, M.J., Bruguera, M., Caballeria, J., and Rodes, J., Malnutrition calórico-proteíca en pacientes hepáticos hospitalizados. Gastroenterología y Hepatología, Vol. 10, n° 9, 1987, pp. 434–440.Google Scholar
  3. 3.
    Leevy, C.M., Baker, H., Hove, W., et al., P-complex vitamins in liver disease of the alcoholic. Am. Jour. of Clin. Nutr. 16, 1965, pp. 339–346.Google Scholar
  4. 4.
    Mezey, E., Liver disease and nutrition. Gastroenterology, 74, 1978, pp. 770–783.PubMedGoogle Scholar
  5. 5.
    Thompson, G.R., Barrowman, J., Gutierrez, L., et al. Actions of Neomycin on the intraluminal phase of lipid absorption. J. Clin. Invest., 50, 1971, pp. 319–323.PubMedCrossRefGoogle Scholar
  6. 6.
    Hashim, S.A., Bergen, S.S., Van Itallie, T.B., Experimental esteatorreha induced in man by bill [sic] acid sequestrant. Proc. Soc. Exp. Biol. Med. 106: 1961, pp. 173–175.PubMedGoogle Scholar
  7. 7.
    Collins, j.R., Lacy, W.W., and Stiel, J.N. et al. Glucose intolerance and insulin resistence in patients with liver disease. II A Study of aetiologic factors and evaluation of insulin actions. Arch. Inter. Med. 127, 1970, pp. 608–614.CrossRefGoogle Scholar
  8. 8.
    Dupre, J., Curtis, J.D., Unger, R.H. et al. Effects of secretin, pancreozymin or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.Google Scholar
  9. 9.
    Goldstein, J.L., Kita, T., and Brown, M.S., Defective lipoprotein receptors and atherosclerosis, lessons from an animal counterpart of Familial Hipercolesterolemia.Google Scholar
  10. 10.
    Brown, M.S., Kovanen, P.T. and Goldstein, J.L., Regulation of plasma cholesterol by lipoprotein. Science 212, 1981, pp. 628–635.PubMedCrossRefGoogle Scholar
  11. 11.
    Hoeg, J.M., Demosky, S.J., and Greff, R.E., Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans. Science 277, 1985, pp. 759–761.CrossRefGoogle Scholar
  12. 12.
    Manley, R.W. and Interarity, J.L., Lipoprotein receptors and cholesterol homeostasis. Biochem. Biophys. Acta 737, 1983, pp. 197–222.CrossRefGoogle Scholar
  13. 13.
    Haussinger, D., Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Am. J. Biochem. 133, 1983, pp. 269–275.Google Scholar
  14. 14.
    Hepner, G.W., Roginsky, M. and Moo, H.F., Abnormal vitamin D metabolism in patient with cirrhosis. Am. J. dis. 21, 1976, pp. 527–532.CrossRefGoogle Scholar
  15. 15.
    Fennelli J., Frank, O., Baker, et al., Red blood cell transketolase activity in malnourished alcoholics with cirrhosis. Am. Jour. Clin. Nutr. 20, 1967, pp. 946–949.Google Scholar
  16. 16.
    Fischer, J.E. and Baldessarini, R.J., False neurotransmitters and hepatic failure. Lancet 2, 1971, pp. 75–85.PubMedCrossRefGoogle Scholar
  17. 17.
    Baldessarini, R.J. and Fischer, J.E., Serotonin metabolism in rat brain after judicial diversion of the portal venoces circulation. Nature 245, 1973, pp. 25–35.CrossRefGoogle Scholar
  18. 18.
    Harnes, H.J., Jepson, B., Ziparo, V., Fischer, J.E., Hyperammonemia plasma aminoacid imbalance, and blood brain aminoacid transport: a unified theory of portal. Lancet ii, 1979, pp. 772.Google Scholar
  19. 19.
    Mans, A., et al., Early establishment of cerebral disfunction after portacaval shunting. Am. Physiol. Soc, 1990, 0193–1849, pp. E104-E106.Google Scholar
  20. 20.
    Cerra, F.B., Cheung, N.K., Fischer, J.E. et al., A multicenter trial of branched chain enriched aminoacid infusiores (F080) in hepatic encephalopathy. Hepatalolgy Z., 1982, pp. 699.Google Scholar
  21. 21.
    Rossi-Fanelli, F., Cascino, A., Cangiano, C., Branched chain aminoacids in the management of hepatic encephalopathy. J. Clin. Gastroenterol. Z., 1987, pp. 44–46.Google Scholar
  22. 22.
    Warren, K.S., Shenker, S., Effect of and inhibitor of Glutamine Synthesis on Ammonia toxicity and metabolism. J. Lab. Clin. Med. 64, 1964, pp. 442.PubMedGoogle Scholar
  23. 23.
    Silk, D.B.A., Parenteral nutrition in patients with liver disease. Journal of Hepatology 7, 1988, pp. 269–277.PubMedCrossRefGoogle Scholar
  24. 24.
    Sastre, A., et al., Nutrición en la insuficiencia hepática. In Nutritión artificial en el paciente grave. Edit. Doyma. Barcelona, 1989, pp. 45–47.Google Scholar
  25. 25.
    Reynolds, J.V., Daly, J.M., et al., Immunomodulatory mechanisms of arginine. Surgery, 104, n° 2, 1988, pp. 143–151.Google Scholar
  26. 26.
    Barbul, A., Lazarou, S.A., Efron, D., et al., Arginine entrances wound healing and lynphocyte immune responses in humans. Surgery, Vol. 108, n° 2, 1990, pp. 331–337.PubMedGoogle Scholar
  27. 27.
    Carda, P., Saastre, A., La Roche, F., Morales, V. and Marcos, J. M. Correction of Aminoacid imbalance in Postoperative portalsystemic Shunts. Infusiontherapie 12, 1985, pp. 251–253.Google Scholar
  28. 28.
    Garcia Almansa, A., et al., Nutrición y hepatopatía, In Introductión a la Nutrición Clínica hospitalaria. P.P. Garcia Luna, Edit. SAS, 1990, pp. 251–260.Google Scholar
  29. 29.
    Muñoz, S.J., Nutritional therapies in liver disease. Seminars in liver disease, Vol. II, n° 4, 1991, pp. 278–291.CrossRefGoogle Scholar
  30. 30.
    Mans, Anke M. et al., Early establishment of cerebral dysfunction after portacaval shunting. Amer. Physiological Soc., 1990, 0193-1849/90, pp. E104–E109.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • A. Sastre Gallego
    • 1
  • E. Morejón Bootello
    • 1
  • P. Carda Abella
    • 1
  1. 1.Dpto. de Cirugia General y Digestiva, Hospital “Ramón y Cajal”Unidad de Nutrición Clínica y DietéticaMadridSpain

Personalised recommendations